Clot lysis time in platelet-rich plasma: Method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid-Reference-Cited by-同舟云学术

Clot lysis time in platelet-rich plasma: Method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid

Published:2011-07-25 Issue:1 Volume:23 Page:36-44
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Panes Olga,Padilla Oslando,Matus Valeria,Sáez Claudia G.,Berkovits Alejandro,Pereira Jaime,Mezzano Diego

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/09537104.2011.596957

Reference55 articles.

1. Haemostatic management of intraoral bleeding in patients with congenital deficiency of alpha2-plasmin inhibitor or plasminogen activator inhibitor-1

2. Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men

3. Hypofibrinolysis as a risk factor for recurrent venous thrombosis; results of the LETS follow-up study

4. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous blood: platelet-rich plasma and platelet-poor plasma;OrthoBiologics;2025

2. Hemostatic Status of Neonates with Perinatal Hypoxia, Studied via NATEM in Cord Blood Samples;Children;2024-06-29

3. Platelet-Rich Plasma Power-Mix Gel (ppm)—An Orthobiologic Optimization Protocol Rich in Growth Factors and Fibrin;Gels;2023-07-07

4. A triple fusion tissue-type plasminogen activator (TriF-ΔtPA) enhanced thrombolysis in carotid embolism-induced stroke model;International Journal of Pharmaceutics;2023-04

5. Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: Association with lipoproteins and C-reactive protein;Vascular Pharmacology;2022-06